Log In
BCIQ
Print this Print this
 

SAR110894

  Manage Alerts
Collapse Summary General Information
Company Sanofi
DescriptionOral histamine H3 receptor antagonist
Molecular Target Histamine H3 receptor (HRH3)
Mechanism of ActionHistamine H3 receptor antagonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat Alzheimer's disease (AD)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today